Zi Long Qian
Directeur Général chez SHENZHEN KINGSINO TECHNOLOGY CO.,LTD.
Fortune : 177 726 $ au 30/04/2024
Postes actifs de Zi Long Qian
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Directeur Général | 28/10/2022 | - |
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
 Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Zi Long Qian
Formation de Zi Long Qian
| China University of Geosciences | Undergraduate Degree |
| Sun Yat-Sen University | Masters Business Admin |
Statistiques
Internationale
| Chine | 5 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
| Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Process Industries |
| Entreprise privées | 1 |
|---|---|
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Health Technology |
- Bourse
- Insiders
- Zi Long Qian
- Expérience